Advanced search
Publication Cover
Journal of Chemotherapy Volume 27, 2015 - Issue 1
Submit an article Journal homepage
77
Views
10
CrossRef citations to date
0
Altmetric
Anticancer Original Research Papers

The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy

Ai-Gui JiangDepartment of Respiratory DiseasesTaizhou People’s Hospital, Taizhou, Jiangsu, P.R. ChinaCorrespondence[email protected]
&
Hui-Yu LuDepartment of Respiratory DiseasesTaizhou People’s Hospital, Taizhou, Jiangsu, P.R. China
Pages 35-39 | Published online: 10 Apr 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Chuan-long Zhang, Meng-qi Gao, Xiao-chen Jiang, Xue Pan, Xi-yuan Zhang, Yi Li, Qian Shen, Yan Chen & Bo Pang. (2023) Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence. Annals of Medicine 55:1, pages 1294-1307.
Read now
Takayuki Fujio, Kazuhisa Nakashima, Tateaki Naito, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Haruyasu Murakami & Toshiaki Takahashi. (2019) Platinum Combination Chemotherapy Is Poorly Tolerated in Malnourished Advanced Lung Cancer Patients with Poor Performance Status. Nutrition and Cancer 71:5, pages 767-771.
Read now

Articles from other publishers (8)

Chuan-Long Zhang, Kui Fan, Meng-Qi Gao & Bo Pang. (2022) Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Pathology and Oncology Research 28.
Crossref
Hisao Imai, Takayuki Kishikawa, Hiroyuki Minemura, Yutaka Yamada, Tatsuya Ibe, Ou Yamaguchi, Atsuto Mouri, Yoichiro Hamamoto, Kenya Kanazawa, Takashi Kasai, Kyoichi Kaira, Takayuki Kaburagi, Koichi Minato, Kunihiko Kobayashi & Hiroshi Kagamu. (2021) Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer. Cancer Medicine 10:20, pages 6971-6984.
Crossref
Kazuhisa Nakashima, Kojiro Hata, Takamasa Hotta, Seiko Tanaka, Yuki Mitarai, Takae Okuno, Akari Tanino, Mika Nakao, Yoshihiro Amano, Megumi Hamaguchi, Tamio Okimoto, Shunichi Hamaguchi, Taishi Nagao, Noriaki Kurimoto, Takeshi Isobe & Yukari Tsubata. (2021) Ability of the Glasgow Prognostic Score to predict the tolerability and efficacy of platinum-combination chemotherapy among elderly patients with advanced non-small cell lung cancer. The Journal of Medical Investigation 68:3.4, pages 260-264.
Crossref
Jing Jin, Kejia Hu, Yongzhao Zhou & Weimin Li. (2017) Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies. The International Journal of Biological Markers 33:2, pages 201-207.
Crossref
Fausto Meriggi, Claudio Codignola, Giordano D. Beretta, Giovanni L. Ceresoli, Alberto Caprioli, Mario Scartozzi, Anna P. Fraccon, Tiziana Prochilo, Chiara Ogliosi & Alberto Zaniboni. (2017) Significance of Neutrophil-to-lymphocyte Ratio in Western Advanced EGFR-mutated Non-small Cell Lung Cancer Receiving a Targeted Therapy. Tumori Journal 103:5, pages 443-448.
Crossref
Lucheng Zhu, Sumei Chen, Shenglin Ma & Shirong Zhang. (2016) Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis. SpringerPlus 5:1.
Crossref
Ai-Gui Jiang, Hong-Lin Chen & Hui-Yu Lu. (2015) The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer. BMC Cancer 15:1.
Crossref
David Hui. (2015) Prognostication of Survival in Patients with Advanced Cancer: Predicting the Unpredictable?. Cancer Control 22:4, pages 489-497.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.